Sitagliptin
Type 2 Diabetes Medication - Merck
A A A Resize Text

QUESTIONS AND ANSWERS ABOUT TAKING CARE OF TYPE 2 DIABETES

The more you learn about type 2 diabetes, the easier it is to take steps toward managing your diabetes. And when you do, you'll get the good feeling that comes from knowing you’re doing the right thing for yourself and the people you love.

Here are answers to the questions most frequently asked about type 2 diabetes and JANUVIA.

JANUVIA (jah-NEW-vee-ah) is a once-daily prescription pill that, along with diet and exercise, helps lower blood sugar levels in adults with type 2 diabetes.

Important Information About JANUVIA

JANUVIA has not been studied with insulin and should not be used to treat patients with type 1 diabetes or diabetic ketoacidosis (increased ketones in the blood or urine) or used if you are allergic to JANUVIA. Your doctor may perform blood tests from time to time to measure how well your kidneys are working. If you have kidney problems, your doctor may prescribe lower doses of JANUVIA.

When JANUVIA is used with a sulfonylurea, low blood sugar (hypoglycemia) can occur. To avoid this risk, your doctor may prescribe lower doses of the sulfonylurea.

Allergic reactions, which may be serious, including rash, hives, and swelling of the face, lips, tongue, and throat that may cause difficulty breathing or swallowing, can occur. If you have an allergic reaction, stop taking JANUVIA and call your doctor right away. The most common side effects include upper respiratory tract infection, stuffy or runny nose and sore throat, and headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please read the Patient Information and discuss it with your doctor. Also available is the Prescribing Information.

JANUVIA is a registered trademark and Steps to Balance is a trademark of Merck & Co., Inc.
This site is intended only for residents of the United States, its territories, and Puerto Rico.
Copyright © 2009 Merck & Co., Inc. All rights reserved.
20950894(1)-06/09-JAN